Reversion of cardiac dysfunction by a novel orally available calcium/calmodulin-dependent protein kinase II inhibitor, RA306, in a genetic model of dilated cardiomyopathy - Concepedia

Concepedia

Publication | Closed Access

Reversion of cardiac dysfunction by a novel orally available calcium/calmodulin-dependent protein kinase II inhibitor, RA306, in a genetic model of dilated cardiomyopathy

53

Citations

39

References

2019

Year

Philippe Beauverger, Marie‐Laure Ozoux, Guillaume Bégis, Valérie Glénat, Véronique Briand, Marie-Claire Philippo, Cyril Daveu, Georges Tavares, Sébastien Roy, Alain Corbier,

Cardiovascular Research

Abstract

This work supports the feasibility of identifying potent orally available CaMKII inhibitors suitable for clinical use to treat heart disease.

References

	Year	Citations

Page 1